Nanogen to Restate Loss for Q1 2008 | GenomeWeb
NEW YORK (GenomeWeb News) – Nanogen disclosed in a regulatory filing with the US Securities and Exchange Commission today that it will restate its net loss for the first quarter of 2008 due to an accounting error.
 
As a result of the restatement, Nanogen’s net loss for the quarter ended March 31 will be $26.4 million rather than the $23 million it previously recorded.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.